Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trazodone/Gabapentin FDC in Painful Diabetic Neuropathy
NCT03749642Phase 2Completed
- Sponsor
- Angelini Pharma
- Start
- Nov 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial of trazodone hydrochloride prolonged-release tablets and gabapentin in diabetic neuropathy (5 arms), sponsored by Angelini Pharma. Primary endpoint: Change of the average daily pain score based on the 11-point Numeric Rating Scale at Day 56. Started Nov 2018; status: completed.
02
Drugs
trazodone hydrochloride prolonged-release tabletsgabapentin
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT03749642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03749642.